Invenshure-Backed Imbio Seeks $2.5m For Medical Imaging Software

Screen Shot 2015-09-08 at 11.40.26 AMMinneapolis healthtech startup Imbio is raising $2.5m in capital according this recent SEC disclosure, indicating just over $1m committed thus far.

Imbio’s specialty is medical imaging software for the diagnosis and tracking of seriously adverse medical conditions like chronic obstructive pulmonary disease and brain tumors.

Last summer, they partnered with the Mayo Clinic on a specialized form of lung cancer software called CANARY, after coming off an oversubscribed $3.7m series A round in November 2013.

Led by CEO Cynthia Maier, Imbio is backed by the Invenshure portfolio, driven by serial tech entrepreneurs and investors Danny Cunagin and Troy Kopischke.  It operates in the same vein as Steady State Imaging (SSI), a previous company led by Cunagin (and backed by Mark Marlow) that was sold to GE in 2011.